Novadaq Technologies Inc.  

(Public, NASDAQ:NVDQ)   Watch this stock  
Find more results for NVDQ
10.26
+1.43 (16.19%)
Jul 28 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 9.87 - 10.92
52 week 8.26 - 14.36
Open 10.92
Vol / Avg. 1.73M/325,708.00
Mkt cap 507.14M
P/E     -
Div/yield     -
EPS -0.49
Shares 56.26M
Beta 1.20
Inst. own     -
Oct 26, 2016
Q3 2016 Novadaq Technologies Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jul 27, 2016
Q2 2016 Novadaq Technologies Inc Earnings Call
Jul 27, 2016
Q2 2016 Novadaq Technologies Inc Earnings Release
Jun 21, 2016
Novadaq Technologies Inc at JMP Securities Life Sciences Conference - Webcast
Jun 14, 2016
Novadaq Technologies Inc at William Blair Growth Stock Conference
Jun 1, 2016
Novadaq Technologies Inc at Craig-Hallum Institutional Investor Conference
May 24, 2016
Novadaq Technologies Inc at UBS Global Healthcare Conference
May 18, 2016
Novadaq Technologies Inc Annual Shareholders Meeting
May 12, 2016
Novadaq Technologies Inc Annual Shareholders Meeting (Estimated)
May 5, 2016
Novadaq Technologies Inc at Deutsche Bank Health Care Conference
More events from DailyFinance »    

Address

5090 Explorer Dr Suite 202
MISSISSAUGA, ON L4W 4T9
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Novadaq Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's segment is medical devices. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The Company's products include SPY, SPY Elite, LUNA and PINPOINT Imaging Systems, SPY Analysis Toolkit, DermACELL and SPY-Q Case Manager. DermACELL is an Acellular Dermal Matrix (ADM) that is used in breast reconstruction surgeries, as well as in the treatment of diabetic foot and venous stasis ulcers, and chronic non-healing wounds.

Officers and directors

Rick Mangat Ph.D. President, Chief Executive Officer
Bio & Compensation  - Reuters
Roger Deck Chief Financial Officer
Bio & Compensation  - Reuters
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Age: 85
Bio & Compensation  - Reuters
Patrice E. Merrin Director
Age: 66
Bio & Compensation  - Reuters
Robert S. White Director
Age: 54
Bio & Compensation  - Reuters
Aaron Davidson Independent Director
Age: 46
Bio & Compensation  - Reuters
Harold O. Koch Jr. Independent Director
Age: 59
Bio & Compensation  - Reuters